Although the benefits promoted by metformin and DPP4 inhibitors on controlling diabetes are well-defined, many investigators have also shown the effects of these drugs beyond glycemia [15,16], especially on endothelial function. This evidence concerns the gene DPP4 and diabetes mellitus.